You are here: Home » News-CM » Companies » News
Business Standard

Granules India gets ANDA approval for Ibuprofen Tablets

Capital Market 

From USFDA

announced that US FDA has approved Abbreviated New Drug Applications (ANDA) for Ibuprofen Tablets USP, 200 mg (OTC) filed by The approved Abbreviated New Drug Applications is the bioequivalent to the reference listed drug product (RLD), Motrin IB Tablets, 200 mg, of Johnson & Johnson Consumer, Inc.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Granules India gets ANDA approval for Ibuprofen Tablets

From USFDA

From USFDA

announced that US FDA has approved Abbreviated New Drug Applications (ANDA) for Ibuprofen Tablets USP, 200 mg (OTC) filed by The approved Abbreviated New Drug Applications is the bioequivalent to the reference listed drug product (RLD), Motrin IB Tablets, 200 mg, of Johnson & Johnson Consumer, Inc.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Granules India gets ANDA approval for Ibuprofen Tablets

From USFDA

announced that US FDA has approved Abbreviated New Drug Applications (ANDA) for Ibuprofen Tablets USP, 200 mg (OTC) filed by The approved Abbreviated New Drug Applications is the bioequivalent to the reference listed drug product (RLD), Motrin IB Tablets, 200 mg, of Johnson & Johnson Consumer, Inc.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22